What’s Happening With Ionis Pharmaceuticals Stock?

In December 2020 we talked about how Ionis Pharmaceuticals stock seems to be oversold, and since then the stock has seen a 15% rise to levels of $54 currently. However, the company’s lackluster Q4 results and 2021 guidance announced last week has weighed on IONS stock over the last few days…

About the Author

has written 23451 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com